NCT02241759
- Conditions
- Dyslipidaemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Covance Clinical Research Unit Ltd Leeds, United Kingdom
Clinical trial condition
Dyslipidemias
Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.
948 public trials
78 recruiting studies
Dyslipidemias trial results
NCT01286311
- Conditions
- Adherence Interventions, Arterial Occlusive Diseases, Arteriosclerosis, +21 more
- Locations
-
- Northwestern Medical Faculty Foundation General Internal Medicine Ambulatory Clinic Chicago, Illinois, United States
NCT02028702
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Dyslipidemia, +11 more
- Locations
-
- Center for Clinical Research, Hospital Vendsyssel Hjørring, North Denmark, Denmark
NCT02331043
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Mahidon University, Nutrition Institute, Center of Innovation and Reference on Food for Nutrition (CIRFON) Phutthamonthon, Changwat Nakhon Pathom, Thailand
NCT02316808
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Site Reference ID/Investigator# 77961 Buenos Aires, Argentina
- Site Reference ID/Investigator# 77957 Buenos Aires, Argentina
- Site Reference ID/Investigator# 77958 Buenos Aires, Argentina
- Site Reference ID/Investigator# 77960 Buenos Aires, Argentina
Completed
The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism
NCT01564550
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemia, +8 more
- Locations
-
- Department of Endocrinology MEA, Aarhus Hospital Aarhus C, Denmark
NCT01408303
- Conditions
- Cardiovascular Disease, Cardiovascular Diseases, Dyslipidemias, +5 more
- Locations
-
- Muscle Shoals, Alabama, United States
- Chandler, Arizona, United States
- Phoenix, Arizona, United States
- Little Rock, Arkansas, United States
Completed
Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes
NCT01156597
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +6 more
- Locations
-
- Diabetes Research Institute Miami, Florida, United States
NCT02288572
- Conditions
- Body Weight, Dyslipidemias, Glucose Metabolism Disorders, +13 more
- Locations
-
Not specified